July 28, 2021
Atsena Therapeutics has retained The Chase Group to identify a Head of Regulatory. Chase is proud to partner with this clinical-stage ocular gene therapy company developing novel treatments for inherited forms of blindness. The Head of Regulatory will be a collaborative leader and strategic thinker with the ability and requirement to roll up their sleeves to play an integral part in the success and direction of the company. If you would like further details regarding this search or would like to learn how The Chase Group can assist your firm, please contact Moira Newbanks at: moira@chasegroup.com.
